(177Lu) rhPSMA-10.1 injection, engineered to improve delivery of radiation to cancer lesions, recently showed promising data in a phase 1 trial1 The goal of the phase 2 study is to further assess this improved profile, together with testing of optimised dosing regimens First patients have…
